IN a communication 1 made to the Academie des Sciences in I925, it was shown that by the admixture, under certain conditions, of concentrated aqueous solutions of the sodium salt of p-hydroxy-m-acetylaminophenyl-arsinic acid (sodium Stovarsol, As = 27 per cent.), and of sodium potassium bismuth tartrate (Bi = 30 per cent.), a copious white precipitate was obtained. This precipitate after being washed and dried at 560 C. gave a yellowish amorphous powder, insoluble in water, but soluble in alkalies. The product on analysis gave figures which showed it to have the composition represented by the formula 
IN a communication 1 made to the Academie des Sciences in I925, it was shown that by the admixture, under certain conditions, of concentrated aqueous solutions of the sodium salt of p-hydroxy-m-acetylaminophenyl-arsinic acid (sodium Stovarsol, As = 27 per cent.), and of sodium potassium bismuth tartrate (Bi = 30 per cent.), a copious white precipitate was obtained. This precipitate after being washed and dried at 560 C. gave a yellowish amorphous powder, insoluble in water, but soluble in alkalies. The product on analysis gave figures which showed it to have the composition represented by the formula This was the first example of this type of bismuth salt of an arsinic acid. It afforded at the same time the first jpportunity of examining the therapeutic effect in human BRITISH JOURNAL OF VENEREAL DISEASES and experimental syphilis of a product containing both arsinic and bismuth in the molecule. In collaboration with MM. Fournier and Schwartz2 we have published in another communication the results obtained in human syphilis by means of this compound. These results were also embodied in a lecture delivered before the Section of Dermatology of the Royal Society of Medicine early in I926.3 Further investigations have led to the recognition of certain new facts which it is proposed to present and discuss in the present paper.* These investigations have been concerned with the following products:
(i) The basic bismuth salt of bismuth p-hydroxy-macetylamino-phenyl-arsinic acid in solution (soluble bistovol).
(2) The basic bismuth salt of p-amino-phenyl-arsinic acid (bismuth arsanilate). ( 3) The basic bismuth salt of N-phenyl-glycinamide-4-arsinic acid (bismuth tryparsamide).
I. SOLUBLE BISTOVOL
This product has been employed in the form of a 2 per cent. or IO per cent. solution. These solutions have been examined (particularly in IO per cent. solution) for toxicity and for their curative action in experimental syphilis (virus Truffi) , and in the spontaneous spirochaetosis of the rabbit (Sp. cuniculi). The 
BISMUTH COMPOUNDS OF ARSINIC ACIDS
Rabbit 776 D. Killed eighteen days after administration of o0oi gm. per kilo (soluble bistovol).
Kidney, i6 micrograms. Rabbit I49 Z. Killed eighteen days after administration of o-oi gm. per kilo (soluble bistovol).
Kidney, 6 micrograms. These figures show that, in the case of the first animal, there was no trace of bismuth remaining in the injected muscle, and that the amount in the kidneys varied in the three cases from 4 to i6 micrograms per gram of dry substance, figures which indicate a rapid absorption and elimination of the metal from eighteen to thirty days after treatment.
The absorption of bismuth, administered in the form of soluble bistovol, produces an intensive action, which constitutes a definite advantage from the point of promptness of therapeutic action. This efficacy is confirmed also by the fact that in every case where we have examined the serum of the animal by the Meinicke reaction, the result has always been negative. Now it is known from the observations of Mutermilch and Nicolau, (5) which have been confirmed by Navarro Y. Martin, that this reaction is always positive in animals affected with scrotal chancres due to virus Truffi and otherwise untreated.
Conclusion.-Soluble bistovol is an arsinic bismuth preparation, the therapeutic efficacy of which in experimental syphilis and spontaneous spirochaetosis (Sp. cuniculi) of the rabbit is of the highest order.
II. SOLUBLE BISTOVOL PER OS
The results obtained in syphilis by oral administration of stovarsol [curative and prophylactic action, Levaditi and Navarro Y. Martin (6)] have led to the carrying out of similar expenments with soluble bistovol. Our first results were so far encouraging that we were led to persevere in this direction, which finally yielded results of practical importance in the treatment of human syphilis. These we propose to publish later in collaboration with M. Foumier. The general conclusion to be drawn from these experiments, which could be supported by many others, is that soluble bistovol (soluble bismuth p-hydroxy-m-acetvlamino-phenyl-arsinate) administered by the mouth is capable of producing a definite therapeutic effect, both in the spontaneous spirochaetosis and experimental (virus Truffi) syphilis of the rabbit, but while in the first of these conditions this therapeutic action is followed by relapses at long intervals, in experimental syphilis (properly socalled), the cure is definite and complete.
This conclusion is drawn, not only from the observable results obtained by the application of this treatment to certain of our experimental syphilitic rabbits, but also, or rather above all, by the experimentally demonstrable, absolute sterility of the chancre nodules and the popliteal ganglia.
It is well known that the lymphatic glands of the popliteal junction, if removed from syphilitic rabbits, are almost constantly virulent. Inoculation of such into normal rabbits results in the production of nodules, rich in spirochoetes after a period of incubation which may be somewhat lengthy (Truffi and Ossola (7), Truffi (8), Brown and Pearce (9), Kolle and his collaborators, etc.). Now the ganglia of the rabbits which were treated with soluble bistovol per os inoculated into the scrotum of normal rabbits have been found to be totally devoid of virulence. The same is to be said of those nodules which persist at the edge of the scrotum for some time after commencement of treatment (cf. the protocols given below).
Exp. Is the activity of bistovol administered per os dependent upon its being in solution ?
The following is typical of our experiments undertaken to determine this point:
Rabbit I00 D, with prepucial lesions containing numerous spirochaetes (Sp. cuniculi), received 022 gin. of (insoluble) bistovol, suspended in a little isotonic saline administered orally. The faeces became black, showing that the compound is dissociated in the intestine and that part of the bismuth so liberated is converted into the sulphide. The spirochaetes disappeared on the fourth day, the lesions commenced to become pale on the second day, and complete and definite cure followed a short time afterwards (Chart VIII.).
This experiment proves that in the rabbit * it is not necessary that bistovol should be administered per os in the form of a solution in order to produce its therapeutic effect. The same result is obtained if it is administered in the insoluble form. The appearance of the faeces shows that on the surface of the intestinal mucosa, by the action of the digestive juices and of the intestinal flora, the product is dissociated into its two components, stovarsol and bismuth, the latter being converted into the darkcoloured sulphide before elimination in the faeces.
Is this elimination partial or complete ? In other words, is some small proportion of the bismuth absorbed by the digestive tract, or is it entirely eliminated with the faecal contents ? That the arsinical portion of the product is absorbed, no one will doubt, knowing how readily stovarsol is absorbed when administered orally. Can the same be said of bismuth ? Experiments undertaken with human patients in collaboration with M. L. Fournier and Mlle. Manin, give the answer in the affirmative.
Without going into the details of these experiments, which will be published elsewhere, in the urine of patients who had received repeated doses of bistovol per os either in soluble form or in tablet form, quantities of bismuth varying from 40 to 8oo micrograms per litre per twenty-four hours have been detected.
One analysis has so far been carried out in the case of the rabbit. This was 925 D, which presented two large scrotal chancres with very numerous spirochaetes, which was killed on the third day after the oral administration of o-i gm. per kilo of soluble bistovol. Spirochaetes had then disappeared.
The There can, therefore, be no room for doubt; administered orally, either in the form of solution or as an insoluble powder, it matters not which, bismuth is absorbed from the product by the intestinal mucous membrane and can be detected either in the organs (kidney and liver) of the rabbit or in the urine in the case of the human subject.
To what extent and by what mechanism does this absorption take place ? It is impossible for us to suggest an answer at the moment.
Whatever it may be, it can only be by reason of this 37 group.bmj.com assimilation of bismuth that the efficacy of the product when given by the mouth can be explained. In our opinion, the bismuth is associated with the arsinic of stovarsol in increasing the curative action. Stovarsol facilitates the absorption of bismuth through the digestive tract, and, on the other hand, the bismuth reinforces the stovarsol, rendering it more spirochaeticidal in its action.
Conclusions.-From the experiments recorded above, it may be concluded that the bismuth salt of p-hydroxym-acetylamino-phenyl-arsinic acid (bistovol) administered in solution by intramuscular injection or in the form of solution or as a solid per os shows such strikingly therapeutic properties that its employment in the treatment of human syphilis is thoroughly justified.
III. BISMUTH ARSANILATE
Basic bismuth salt of p-amino-phenyl-arsinic acid. Following the publication of our researches on bistovol, J. 0. Shircore (io) effected the preparation of bismuth arsanilate and investigated the effects of this product in the treatment of syphilis and of yaws, the results of which were published in the Lancet of last year.
We have ourselves prepared and examined this compound with a view to studying its spirochoeticidal properties in experimental syphilis. Bismuth tryparsamide is a white amorphous powder.
It has been emploved in the form of a IO per cent. suspension in oil. Its curative action has been shown in the natural spirochaetosis of the rabbit (Sp. cuniculi). Rabbit 676 N. Prepucial lesions with numerous spirochaetes (Sp. cuniculi). Received intramuscularly ori gm. per kilo bismuth tryparsamide. The spirochoetes disappeared on the second day, and the lesions were cured on the twelfth day.
The delay in the cicatrisation of the spirochaetal lesions seems to indicate that this product is less active than the two already mentioned, but further experiments are required to properly evaluate the therapeutic efficiency of the compound, which may possibly be of greater interest from the point of view of treatment of tertiary syphilis of the central nervous system, tabes and general paralysis.
Conclusion.-Since the preparation of the basic bismuth salt of p-hydroxy-m-acetylamino-phenyl-arsinic acid (Levaditi) , other derivatives of the same series have been prepared, e.g., bismuth arsanilate and bismuth tryparsamide. It has also been possible to prepare these products in a soluble form, and the activity of these products against experimental (virus Truffi) and natural spirochaetosis of the rabbit (Sp. cuniculi) when administered either intramuscularly or per os has been determined. Of these, we would lay special stress on bismuth hydroxy-acetylaminophenyl-arsinic acid (bismuth sto-4I 
